Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity.
Saved in:
| Title: | Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity. |
|---|---|
| Authors: | Saburi M; Department of Hematology, Oita Prefectural Hospital, Oita, JPN., Maehara K; Department of Hematology, Oita Prefectural Hospital, Oita, JPN., Nishikawa T; Department of Hematology, Oita Prefectural Hospital, Oita, JPN., Hiroyuki T; Department of Hematology, Oita Prefectural Hospital, Oita, JPN., Sakata M; Hematology, Oita Kouseiren Tsurumi Hospital, Beppu, JPN., Kohno K; Hematology, Oita Kouseiren Tsurumi Hospital, Beppu, JPN., Ogata Y; Hematology, National Hospital Organization Beppu Medical Center, Beppu, JPN., Haruyama T; Hematology, Japan Community Health Care Organization (JCHO) Nankai Medical Center, Saiki, JPN., Ohtsuka E; Department of Hematology, Oita Prefectural Hospital, Oita, JPN. |
| Source: | Cureus [Cureus] 2026 May 06; Vol. 18 (5), pp. e108385. Date of Electronic Publication: 2026 May 06 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2168-8184 |
|---|---|
| DOI: | 10.7759/cureus.108385 |
